Roche develops new research test kits for Omicron variant




  • In US
  • 2021-12-03 06:18:34Z
  • By Reuters
 

By Brenna Hughes Neghaiwi

ZURICH (Reuters) - Roche's newly acquired subsidiary TIB Molbiol has developed three new test kits to help researchers detect mutations in the new Omicron variant of coronavirus, Roche said on Friday.

Governments around the world are urgently scouring databases for recent cases of COVID-19 infections, screening travellers and decoding the viral genomes of the new variant as they try to measure how far it has spread.

Last week, the World Health Organization (WHO) classified Omicron as a SARS-CoV-2 "variant of concern", saying it might spread more quickly than other forms.

"We are able to offer a test that can specifically identify the novel B.1.1.529 Omicron SARS-CoV-2 variant to help better understand its spread and behaviour," Thomas Schinecker, head of Roche Diagnostics, said in a statement.

While the WHO has said widely available tests can detect individuals infected with any variant, most PCR tests cannot distinguish between Omicron and Delta, the dominant and most infectious version of the virus.

Until now, the world body has recommended only the TaqPath test produced by U.S. firm Thermo Fisher as a proxy.

The new Roche and TIB Molbiol testing kits, made only for research use, can differentiate between unique mutations in Omicron compared to other SARS-CoV-2 variants, Roche said.

They can thus help researchers detect Omicron and study its spread versus other variants. Roche said they could also be used to monitor the potential impact of therapeutics, vaccines, and public health interventions on the spread of variants.

Roche acquired Berlin-based TIB Molbiol on Dec. 1 to expand its PCR-test portfolio to combat new infectious diseases.

(Reporting by Brenna Hughes Neghaiwi; Editing by Paul Carrel and Clarence Fernandez)

COMMENTS

More Related News

Spain
Spain's infection rate drops for first time in Omicron wave
  • US
  • 2022-01-18 18:46:42Z

Spain's coronavirus infection rate dropped for the first time in two and a half months, health ministry data showed on Tuesday, suggesting the Omicron...

What you need to know about the coronavirus right now
What you need to know about the coronavirus right now
  • US
  • 2022-01-18 12:49:43Z

Australia suffered its deadliest day of the pandemic on Tuesday as a fast-moving Omicron outbreak continued to push up hospitalisation rates to record levels...

Israel sticks with 4th vaccine shot, sees Omicron wave waning in a week
Israel sticks with 4th vaccine shot, sees Omicron wave waning in a week
  • US
  • 2022-01-18 07:53:19Z

JERUSALEM (Reuters) -Israel will continue to offer a fourth COVID-19 vaccine shot despite preliminary findings that it is not enough to prevent Omicron...

Japan sees record 27,000 COVID-19 cases as government mulls curbs - media
Japan sees record 27,000 COVID-19 cases as government mulls curbs - media
  • US
  • 2022-01-18 03:15:47Z

TOKYO (Reuters) -Japan's new COVID-19 cases jumped to a record on Tuesday, local media reported, as the government considered expanding measures to contain...

Australia suffers deadliest day of pandemic as Omicron drives up hospital cases
Australia suffers deadliest day of pandemic as Omicron drives up hospital cases
  • US
  • 2022-01-18 01:30:13Z

Australia suffered its deadliest day of the pandemic on Tuesday as a fast-moving Omicron outbreak continued to push up hospitalisation rates to record levels...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US